Gilder Gagnon Howe & CO LLC Quotient LTD Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 16, 2021	SELL	$4.4 - $7.32 $487,555 - $811,114	-110,808 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.38 - $8.35 $1.32 Million - $2.52 Million	-301,607 Reduced 73.13%	110,808 $570,000
Q2 2020 Aug 14, 2020	SELL	$3.64 - $9.26 $525,612 - $1.34 Million	-144,399 Reduced 25.93%	412,415 $3.05 Million
Q1 2020 May 15, 2020	SELL	$2.54 - $9.38 $5,173 - $19,107	-2,037 Reduced 0.36%	556,814 $2.2 Million
Q4 2019 Feb 14, 2020	BUY	$7.07 - $9.51 $787,640 - $1.06 Million	111,406 Added 24.9%	558,851 $5.32 Million
Q3 2019 Nov 14, 2019	BUY	$7.77 - $11.26 $652 - $945	84 Added 0.02%	447,445 $3.48 Million
Q2 2019 Aug 13, 2019	BUY	$7.91 - $10.25 $3.54 Million - $4.59 Million	447,361 New	447,361 $4.18 Million
Q3 2018 Oct 30, 2018	SELL	$6.57 - $8.31 $1.39 Million - $1.76 Million	-211,990 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$3.93 - $8.93 $833,120 - $1.89 Million	211,990 New	211,990 $1.7 Million

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.